AI Terminal
HIKMA Pharmaceuticals PLC
Director's Dealing • Aug 13, 2025
4841_dirs_2025-08-13_38099ec0-db79-4f21-acd3-7dc73354e0d3.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 2177V
Hikma Pharmaceuticals Plc
13 August 2025
Hikma Pharmaceuticals PLC - PDMR Exercise of Share Awards
LONDON, 13 April 2025: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Person Discharging Managerial Responsibility ("PDMR") has received shares and sold sufficient to cover tax as a result of the exercise of options granted at nil-cost on 17 March 2016, 13 April 2017 and 16 May 2018 under the 2014 Executive Incentive Plan ("EIP").
Notification and public disclosure of transactions by persons discharging managerial responsibilities
| 1 | Details of the person discharging managerial responsibilities / person closely associated | ||
| a) | Name | Susan Ringdal | |
| 2 | Reason for the notification | ||
| a) | Position/status | PDMR | |
| b) | Initial notification /Amendment | Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name | Hikma Pharmaceuticals PLC | |
| b) | LEI | 549300BNS685UXH4JI75 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
| b) | Nature of the transaction | Acquisition of Shares pursuant to the exercise of options granted at nil-cost under the EIP | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| Nil | 60,225 | ||
| d) | Aggregated information | Price(s): nil Volume(s): 60,225 |
|
| e) | Date of the transaction | 12 August 2025 | |
| f) | Place of the transaction | London Stock Exchange (XLON) | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument and identification code | Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
| b) | Nature of the transaction | Shares sold to cover tax following the exercise of options granted at nil-cost under the EIP. | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| £17.76 | 28,393 | ||
| d) | Aggregated information | Price(s): £ 17.76 Volume(s): 28,393 Total(s): £504,191.77 |
|
| e) | Date of the transaction | 12 August 2025 | |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Helen Middlemist
Group Company Secretary
+44 (0)20 7399 2760
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHBDGDIGUBDGUX